文献速递类风湿关节炎

类风湿关节炎达标治疗实施的障碍、促进因素与支持干预:一项系统综述

Barriers to, Facilitators of, and Interventions to Support Treat-to-Target Implementation in Rheumatoid Arthritis: A Systematic Review.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2024-09-04

该系统综述在多个数据库检索类风湿关节炎达标治疗实施相关文献,分析146篇文章,从76项研究中识别329条障碍与促进因素陈述并归为18个目标领域,从70项研究中识别56项干预措施,其中36项改善了达标治疗实施和/或患者结局。

要点

  • 76项研究识别329条障碍与促进因素陈述,归为18个目标领域,涉及知识、沟通、时间与资源等。
  • 70项研究识别56项干预措施,54%针对疾病活动度或患者报告结局评估。
  • 56项干预中36项改善了达标治疗实施和/或患者结局。

核心结论

  • 尽管达标治疗推荐已建立很久,其实施仍存在许多障碍。
  • 改善达标治疗的干预措施应进一步开发和评估,尤其应针对不同国家、地区和医疗环境进行定制。

研究设计与样本

  • 系统综述与范围综述,在PubMed/MEDLINE、BIOSIS Previews、Derwent Drug File、Embase、EMCare、International Pharmaceutical Abstracts和SciSearch进行系统与范围文献检索。
  • 共分析146篇文章,其中123篇(84%)包含≥50%的CASP清单评估条目。

主要发现

  • 146项研究中76项评估达标治疗的障碍与促进因素,识别329条相关陈述并重新归为18个目标领域,包括卫生保健专业人员(HCP)或患者的知识或认知、患者-HCP沟通或一致性、时间或资源。
  • 70项研究在18个目标领域中识别56项干预措施,其中54%针对疾病活动度或患者报告结局评估。
  • 56项干预措施中36项改善了类风湿关节炎的达标治疗实施和/或患者结局。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Treat-to-target is recommended in the management of rheumatoid arthritis (RA) but its implementation is suboptimal. We aimed to identify interventional strategies targeted at improving treat-to-target implementation in RA by systematically reviewing published evidence on barriers to, facilitators of, and interventions to support treat-to-target implementation. METHODS: Systematic and scoping literature searches in PubMed/MEDLINE, BIOSIS Previews, Derwent Drug File, Embase, EMCare, International Pharmaceutical Abstracts, and SciSearch were conducted to identify barriers/facilitators and interventions relating to treat-to-target implementation in RA. The quality of included studies was assessed using Critical Appraisal Skills Programme (CASP) checklists. Data related to barriers/facilitators and interventions were extracted, grouped, and summarized descriptively, and a narrative synthesis was generated. RESULTS: In total, 146 articles were analyzed, of which 123 (84%) included ≥50% of the items assessed by CASP checklists. Of the 146 studies, 76 evaluated treat-to-target barriers and facilitators, from which 329 relevant statements were identified and regrouped into 18 target areas, including health care professional (HCP) or patient knowledge or perceptions; patient-HCP communication or alignment; and time or resources. Overall, 56 interventions were identified from 70 studies across the 18 target areas; 54% addressed disease activity or patient-reported outcome assessments. Of the 56 interventions identified, 36 improved treat-to-target implementation and/or patient outcomes in RA. CONCLUSION: Despite long-established treat-to-target recommendations, there remain many barriers to its implementation. Interventions to improve treat-to-target should be developed further and assessed, with a particular focus on tailoring them to individual countries, regions, and health care settings.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Gossec L, Bessette L, Xavier RM, et al. Barriers to, Facilitators of, and Interventions to Support Treat-to-Target Implementation in Rheumatoid Arthritis: A Systematic Review. Arthritis Care Res (Hoboken). 2024. PMID: 39090845. doi:10.1002/acr.25408

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。